XML 20 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Discontinued Operations and Assets Held for Sale
6 Months Ended
Jun. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations and Assets Held for Sale
Discontinued Operations and Assets Held for Sale

The Company explored opportunities during the second quarter of 2017 to sell the separate business representing: 1) CoSense® End-Tidal Carbon Monoxide (ETCO) Monitor, or CoSense, which measures ETCO and 2) NFI, a wholly owned subsidiary that sells innovative pulmonary resuscitation solutions for the inpatient and ambulatory neonatal markets. NFI’s primary product is the NeoPip T-piece resuscitator and related consumable, which delivers consistent pre-set inspiratory pressure and positive end-expiratory pressures. Other NFI products include temperature probes, scales, surgical tables and patient surfaces.

Under ASC 205-20-45-10, during the period in which a component meets the assets held for sale and discontinued operations criteria, an entity must present the assets and liabilities of the discontinued operation separately in the asset and liability sections of the balance sheet for the comparative reporting periods. The prior period balance sheet should be reclassified for the held for sale items.
For income statements, the current and prior periods should report the results of operations of the component in discontinued operations when comparative income statements are presented.
The components of the balance sheet accounts presented as assets and liabilities held for sale were as follows:

 
June 30, 2017
 
December 31, 2016
Current assets
 
 
 
Accounts receivable
$
153

 
$
130

Inventory
652

 
660

Property & equipment, net
32

 

Goodwill
718

 

Other intangible assets
768

 

Current assets held for sale
$
2,323

 
$
790

 
 
 
 
Long-term assets
 
 
 
Property & equipment, net
$

 
$
48

Goodwill

 
$
718

Other intangible assets

 
818

Long-term assets held for sale

 
1,584

 
 
 
 
Current liabilities
 
 
 
Accounts payable
$
48

 
$
127

Accrued compensation and other current liabilities
135

 
119

Other long-term liabilities
31

 

Total current liabilities for sale
$
214

 
$
246

 
 
 
 
Long-term liabilities
 
 
 
Other long-term liabilities
$

 
$
81

Long-term liabilities held for sale

 
81











The components of the income statement accounts presented as Discontinued Operations were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2017
 
2016
 
2017
 
2016
Product revenue
$
375

 
$
389

 
$
637

 
$
835

Cost of product revenue
281

 
377

 
489

 
820

    Gross profit (loss)
94

 
12

 
148

 
15

Expenses
 
 
 
 
 
 
 
Research and development
452

 
669

 
914

 
1,476

Sales and marketing
93

 
410

 
180

 
752

General and administrative
252

 
87

 
395

 
176

    Total expenses
797

 
1,166

 
1,489

 
2,404

    Operating loss
(703
)
 
(1,154
)
 
(1,341
)
 
(2,389
)
Other income (expense)
(24
)
 
8

 
(29
)
 
27

Loss from discontinued operations
$
(727
)
 
$
(1,146
)
 
$
(1,370
)
 
$
(2,362
)